Practice

COPD: Why one moderate exacerbation changes everything

One moderate COPD exacerbation should prompt clinicians to consider stepping up from dual bronchodilator therapy to a single-inhaler triple therapy.

Beyond the numbers: What your PFT results are really telling you

Pulmonary function tests require an approach beyond simple normal/abnormal classifications, integrating clinical context and patient demographics for accurate diagnosis.

OPEP therapy: Is your current mucus clearance falling short?

Oscillating positive expiratory pressure (OPEP) therapy offers a non-pharmacological approach to mucus clearance across various respiratory conditions.

Pulmonary Hypertension: Your objective measures aren't telling the whole story

Patient-reported outcomes are essential for understanding the true burden of pulmonary arterial hypertension and guiding treatment decisions.

Why CPAP success isn't about the device, but the patient experience

Optimising CPAP therapy requires a shift from device-centric views to patient-centred care, addressing comfort, education, and ongoing support.

Central sleep apnea: Why aren't we using ASV more?

Auto-servo ventilation (ASV) therapy is a guideline-recommended treatment for central sleep apnea (CSA), but its adoption in clinical practice remains inconsistent. Understanding ASV's mechanism and patient selection is important for optimal outcomes.

Titration: Why 'Start Low, Go Slow' Isn't Always the Safest Path

Optimal drug titration balances efficacy and tolerability, but patient-reported signals and clinical plateaus often complicate dose adjustments. Understanding these dynamics is essential for achieving therapeutic goals.

GLP-1s and hair loss: Is it the drug or the diet?

Rapid weight loss from GLP-1 receptor agonists can trigger telogen effluvium, a temporary hair shedding condition. Clinicians should counsel patients on this potential side effect and its management.

BPH: Why alpha-blockers aren't always enough

Benign prostatic hyperplasia management in primary care extends beyond initial pharmacotherapy, requiring a careful approach to diagnosis, patient selection, and advanced interventions.